PARP1 EXPRESSION IS A STRONG PROGNOSTIC BIOMARKER IN MULTIPLE MYELOMA PATIENTS RECEIVING AUTOLOGOUS STEM CELL TRANSPLANT.

被引：0
作者：
Thomas, M. [1 ]
King, K. [2 ]
Seligson, N. [2 ]
机构：
[1] Univ Florida, Orlando, FL USA
[2] Univ Florida, Jacksonville, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2022年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P-179
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [41] High Expression of AF1q Is an Adverse Prognostic Factor in Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation
    Hagiwara, Shotaro
    Schiefer, Ana-Iris
    Mine, Sohtaro
    Kenner, Lukas
    Tse, William
    BLOOD, 2015, 126 (23)
  • [42] THE IMPLICATIONS OF AGE FOR DEPRESSION AND FATIGUE IN MULTIPLE MYELOMA PATIENTS RECEIVING AUTOLOGOUS STEM CELL TRANSPLANTION
    Sommer, Kathryn
    Granski, Julia
    Hoffman-Peterson, Ariella
    Prescott, Nina
    Winkel, Gary
    Valdimarsdottir, Heiddis
    Redd, William
    Figueiro, Mariana
    ANNALS OF BEHAVIORAL MEDICINE, 2019, 53 : S551 - S551
  • [43] Complete response after autologous stem cell transplant in multiple myeloma
    Kumar, Lalit
    Iqbal, Nida
    Mookerjee, Anjali
    Verma, Rakesh Kumar
    Sharma, Om D.
    Batra, Atul
    Pramanik, Raja
    Gupta, Ritu
    CANCER MEDICINE, 2014, 3 (04): : 939 - 946
  • [44] Dendritic cell reconstitution following autologous stem cell transplant for multiple myeloma
    Schlueter, AJ
    Glasgow, JK
    Wilke, WW
    Marietta, JR
    Hohl, RJ
    Carter, TH
    Gingrich, RD
    Magalhaes-Silverman, MD
    BLOOD, 2005, 106 (11) : 386B - 387B
  • [45] Conditioning Chemotherapy with BORMEL in Autologous Stem Cell Transplant in Multiple Myeloma
    Alvarez, Jose L., Sr.
    Pacheco, M. Augusta
    Guzman, Pedro
    Montoya, Leire
    Mena, Veronica
    Ortiz, Maricela
    Jimenez, Rosa
    Alvarado, Martha
    BLOOD, 2017, 130
  • [46] Management of Relapsed Multiple Myeloma after Autologous Stem Cell Transplant
    Holstein, Sarah A.
    Richardson, Paul G.
    Laubach, Jacob P.
    McCarthy, Philip L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (05) : 793 - 798
  • [47] Outcomes Following Salvage Autologous Stem Cell Transplant for Multiple Myeloma
    Fein, Daniel E.
    Hassoun, Hani
    Comenzo, Raymond L.
    Lesokhin, Alex
    Lendvai, Nikoletta
    Chung, David
    Cohen, Adam
    Rosenzweig, Michael A.
    Chimento, Danielle
    Jia, Xiaoyu
    Nimer, Stephen
    Giralt, Sergio
    Landau, Heather
    BLOOD, 2010, 116 (21) : 581 - 581
  • [48] Second Autologous Stem Cell Transplant As Salvage Therapy For Multiple Myeloma
    Elemary, Mohamed
    Emara, Mohamed
    Sharma, Ankur
    Sarker, Sabuj
    Sabry, Waleed
    Stakiw, Julie
    BLOOD, 2013, 122 (21)
  • [49] Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantation.
    Schimmer, AD
    MacKinnon, J
    Meharchand, J
    Keating, A
    Crump, RM
    Sutton, DM
    Shepherd, FA
    Stewart, AK
    BLOOD, 1997, 90 (10) : 4387 - 4387
  • [50] Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation
    Jingyu Xu
    Wenqiang Yan
    Huishou Fan
    Jiahui Liu
    Lingna Li
    Chenxing Du
    Shuhui Deng
    Weiwei Sui
    Yan Xu
    Lugui Qiu
    Gang An
    Annals of Hematology, 2023, 102 : 3195 - 3204
12345